Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors
August 29, 2017 06:44 ET
|
Genmab A/S
Company Announcement
Seattle Genetics exercises option to co-develop & co-commercialize tisotumab vedotin
Costs and profits to be shared 50:50 going forward
Lead...
Genmab Announces Positive Topline Results in Phase III ALCYONE Study of Daratumumab in Front Line Multiple Myeloma
August 24, 2017 09:22 ET
|
Genmab A/S
Company Announcement
Phase III ALCYONE study of daratumumab in combination with bortezomib, melphalan and prednisone (VMP) in front line multiple myeloma met the primary endpoint at a...
Selskabsvedtægter for Genmab A/S
August 16, 2017 11:17 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 15. august 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
August 16, 2017 11:17 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated August 15, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
August 15, 2017 12:05 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; August 15, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 21,070 shares as a consequence of the exercise of employee...
Genmab Announces Financial Results for the First Half of 2017
August 09, 2017 11:03 ET
|
Genmab A/S
August 9, 2017; Copenhagen, Denmark;
Interim Report for the First Half of 2017
Highlights
USD 554 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK 454...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2017
July 18, 2017 07:03 ET
|
Genmab A/S
Company Announcement
Net sales of DARZALEX in the second quarter of 2017 totaled USD 299 million
Genmab will receive royalties on worldwide net sales from Janssen Biotech,...
Selskabsvedtægter for Genmab A/S
June 28, 2017 08:49 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 27. juni 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
June 28, 2017 08:49 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated June 27, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
June 27, 2017 11:13 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; June 27, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 163,164 shares as a consequence of the exercise of employee...